HomeCompareHLUBF vs VICI

HLUBF vs VICI: Dividend Comparison 2026

HLUBF yields 3.77% · VICI yields 6.52%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VICI wins by $945.9K in total portfolio value
10 years
HLUBF
HLUBF
● Live price
3.77%
Share price
$4.82
Annual div
$0.18
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.3K
Annual income
$0.38
Full HLUBF calculator →
VICI
VICI Properties Inc.
● Live price
6.52%
Share price
$27.32
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$966.2K
Annual income
$607,376.13
Full VICI calculator →

Portfolio growth — HLUBF vs VICI

📍 VICI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHLUBFVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HLUBF + VICI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HLUBF pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HLUBF
Annual income on $10K today (after 15% tax)
$320.43/yr
After 10yr DRIP, annual income (after tax)
$0.32/yr
VICI
Annual income on $10K today (after 15% tax)
$554.58/yr
After 10yr DRIP, annual income (after tax)
$516,269.71/yr
At 15% tax rate, VICI beats the other by $516,269.39/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HLUBF + VICI for your $10,000?

HLUBF: 50%VICI: 50%
100% VICI50/50100% HLUBF
Portfolio after 10yr
$493.3K
Annual income
$303,688.25/yr
Blended yield
61.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

HLUBF
No analyst data
Altman Z
2.1
Piotroski
5/9
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+15.7% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HLUBF buys
0
VICI buys
0
No recent congressional trades found for HLUBF or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHLUBFVICI
Forward yield3.77%6.52%
Annual dividend / share$0.18$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%44.3%
Portfolio after 10y$20.3K$966.2K
Annual income after 10y$0.38$607,376.13
Total dividends collected$381.00$926.2K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: HLUBF vs VICI ($10,000, DRIP)

YearHLUBF PortfolioHLUBF Income/yrVICI PortfolioVICI Income/yrGap
1← crossover$10,888$188.49$11,361$941.49$473.00VICI
2$11,747$95.90$13,320$1,481.32$1.6KVICI
3$12,617$48.35$16,284$2,405.01$3.7KVICI
4$13,525$24.27$21,040$4,071.78$7.5KVICI
5$14,484$12.15$29,209$7,285.49$14.7KVICI
6$15,503$6.08$44,443$14,006.51$28.9KVICI
7$16,592$3.04$75,822$29,512.55$59.2KVICI
8$17,755$1.52$148,733$69,726.75$131.0KVICI
9$18,998$0.76$344,394$189,413.75$325.4KVICI
10$20,329$0.38$966,234$607,376.13$945.9KVICI

HLUBF vs VICI: Complete Analysis 2026

HLUBFStock

H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer's disease; Onfi for Lennox-Gastaut syndrome; Sabril for treating epilepsy; and Xenazine for chorea associated with Huntington's disease, as well as other products. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership agreement with Verantos to focus on a study to enable real-world evidence in support of migraine therapy; and collaboration with Rgenta Therapeutics, Inc. The company was founded in 1915 and is headquartered in Valby, Denmark.

Full HLUBF Calculator →

VICIREIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this HLUBF vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HLUBF vs SCHDHLUBF vs JEPIHLUBF vs OHLUBF vs KOHLUBF vs MAINHLUBF vs NNNHLUBF vs EPRTHLUBF vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.